KEI Files Expedited FOIA Request Regarding NIH Prospective Exclusive License of CAR T Technology
Update: the NIH has rejected our request for expedited processing of the FOIA, on the grounds that KEI did not demonstrate “that there exists an urgency to inform the public” about the costs of the NIH CAR T or mesothelin… Continue Reading